Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: Zika

From AIDS to Zika: ‘What’s next?’ asked Dr. Anthony Fauci in keynote address at the 2017 ACR/ARHP Annual Meeting

Keri Losavio  |  November 5, 2017

SAN DIEGO—The 2017 ACR/ARHP Annual Meeting kicked off on Nov. 4 with a rousing presentation by Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases (NIAID). A terrorist attack on U.S. soil, hurricane, cyberattack and pandemic were the four scenarios played out in late 2016, when NIAID conducted a tabletop…

Filed under:Meeting Reports Tagged with:2017 ACR/ARHP Annual Meeting

Why Rheumatologists Should Care about Zika: How It’s Transmitted & Spreading in the U.S.

Lara C. Pullen, PhD  |  September 26, 2016

Rheumatologists are already familiar with one mosquito-borne virus, chikungunya, whose presentation mimics arthritis. Now, with its recent spread to Puerto Rico and the Southeastern U.S., Zika, another mosquito-borne virus, has become an international public health concern. Sexual transmission of the virus was recently confirmed, expanding the virus’s threat…

Filed under:Conditions Tagged with:chikungunyaInternationaloutbreakspublic health

Where Viral Infections Meet Rheumatic Disease

Jason Liebowitz, MD, FACR  |  November 21, 2023

SAN DIEGO—Viral infections are a common cause of acute arthritis and, in general, tend to be short lived and are not usually associated with significant articular inflammation. Due to the prevalence of various viral infections across the globe, any patient with signs of early inflammatory arthritis (i.e., symptoms that have not yet lasted six weeks) should be evaluated for a possible infectious etiology, said Dr. Leonard Calabrese in the Review Course at ACR Convergence 2023.

Filed under:ACR ConvergenceConditionsMeeting Reports Tagged with:ACR Convergence 2023

Chikungunya Virus May Lead to Long-Term Joint Pain

Linda Childers  |  November 18, 2020

COVID-19 isn’t the only viral infection on the rise across the globe, so is chikungunya, which can cause arthritis-like symptoms and may lead to long-term joint pain.

Filed under:ConditionsPain Syndromes Tagged with:arthritis painchikungunyaCHIKVChronic painJoint Pain

Inaugural ACR Distinguished Global Public Health Award Presented to Dr. Fauci

Susan Bernstein  |  November 11, 2020

ACR CONVERGENCE 2020—At the ACR’s fully virtual annual meeting on Saturday, Nov. 7, ACR President Ellen M. Gravallese, MD, chief of the Division of Rheumatology, Inflammation and Immunity at Brigham and Women’s Hospital, Boston, presented the inaugural ACR Distinguished Global Public Health Award to Anthony S. Fauci, MD, director of the National Institute of Allergy…

Filed under:ACR ConvergenceAwardsMeeting ReportsProfessional Topics Tagged with:ACR Convergence 2020Anthony S. Fauci

ACR Convergence 2020

ACR Convergence 2020: Progress Toward COVID-19 Vaccines

Ruth Jessen Hickman, MD  |  November 11, 2020

ACR CONVERGENCE 2020—A scientific session on Sunday, Nov. 8, focused on vaccine prospects in COVID-19. Dan Barouch, MD, PhD, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center and the William Bosworth Castle Professor of Medicine at Harvard Medical School in Boston, shared his insights about vaccine development across…

Filed under:ACR ConvergenceMeeting Reports Tagged with:ACR Convergence 2020COVID-19vaccinevaccines

ACR Convergence 2020: Reimagining the ACR/ARP Annual Meeting

Ellen M. Gravallese, MD  |  August 5, 2020

Looking back on last year’s ACR/ARP annual meeting, I recall the energy and excitement of attendees as they participated in sessions covering the latest scientific concepts and new directions in our field. In 2019, we piloted a number of innovative ways to modernize and enhance future ACR meetings, with the promise of delivering a transformed…

Filed under:Education & TrainingPresident's Perspective Tagged with:ACR Convergence 2020

The ACR Expresses Strong Support for Dr. Anthony Fauci

From the College  |  July 29, 2020

The ACR, on behalf of its more than 7,700 members of the professional rheumatology community, wishes to express strong support for Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases (NIAID), and his continued and close involvement in the work to address the nation’s response to the COVID-19 pandemic. During…

Filed under:Professional Topics Tagged with:ACR Convergence 2020Anthony S. FauciCOVID-19

Florida Society of Rheumatology in the Spotlight

Linda Childers  |  June 18, 2020

Advocacy efforts on access and workforce issues in Florida are discussed.

Filed under:Professional Topics Tagged with:Dr. Guillermo ValenzuelaDr. Reshma KhanFlorida Society of Rheumatologystate society

Chikungunya Virus Vaccine Shows Promise in Early Clinical Trial

Will Boggs, MD  |  April 21, 2020

NEW YORK (Reuters Health)—A new chikungunya virus-like-particle vaccine appears to be safe and immunogenic, according to results from a phase 2 trial. “The phase 2 safety, tolerability and immunogenicity were similar to the data seen in an earlier phase 1 study,” Grace L. Chen, MD, of the National Institutes of Health Vaccine Research Center, Bethesda,…

Filed under:Conditions Tagged with:chikungunyaCHIKVpolyarthritisvaccine

  • 1
  • 2
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences